BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Czogalla B, Kahaly M, Mayr D, Schmoeckel E, Niesler B, Hester A, Zeder-Göß C, Kolben T, Burges A, Mahner S, Jeschke U, Trillsch F. Correlation of NRF2 and progesterone receptor and its effects on ovarian cancer biology. Cancer Manag Res 2019;11:7673-84. [PMID: 31616183 DOI: 10.2147/CMAR.S210004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Kraus FBT, Topalov NE, Deuster E, Hysenaj I, Mayr D, Chelariu-Raicu A, Beyer S, Kolben T, Burges A, Mahner S, Trillsch F, Jeschke U, Czogalla B. Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer. J Cancer Res Clin Oncol 2022. [PMID: 35751684 DOI: 10.1007/s00432-022-04114-x] [Reference Citation Analysis]
2 Badmann S, Mayr D, Schmoeckel E, Hester A, Buschmann C, Beyer S, Kolben T, Kraus F, Chelariu-Raicu A, Burges A, Mahner S, Jeschke U, Trillsch F, Czogalla B. AKR1C1/2 inhibition by MPA sensitizes platinum resistant ovarian cancer towards carboplatin. Sci Rep 2022;12:1862. [PMID: 35115586 DOI: 10.1038/s41598-022-05785-9] [Reference Citation Analysis]
3 Chu X, He S, Liu Y, Liu Y, Feng F, Guo Q, Zhao L, Sun H. Overview of human 20 alpha-hydroxysteroid dehydrogenase (AKR1C1): Functions, regulation, and structural insights of inhibitors. Chem Biol Interact 2021;351:109746. [PMID: 34780792 DOI: 10.1016/j.cbi.2021.109746] [Reference Citation Analysis]
4 Su T, Yu H, Luo G, Wang M, Zhou C, Zhang L, Hou B, Zhang C, Liu M, Xu D. The Interaction of lncRNA XLOC-2222497, AKR1C1, and Progesterone in Porcine Endometrium and Pregnancy. Int J Mol Sci 2020;21:E3232. [PMID: 32370225 DOI: 10.3390/ijms21093232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li D, Hong X, Zhao F, Ci X, Zhang S. Targeting Nrf2 may reverse the drug resistance in ovarian cancer. Cancer Cell Int 2021;21:116. [PMID: 33596893 DOI: 10.1186/s12935-021-01822-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Tossetta G, Fantone S, Montanari E, Marzioni D, Goteri G. Role of NRF2 in Ovarian Cancer. Antioxidants 2022;11:663. [DOI: 10.3390/antiox11040663] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]